What is the treatment for acetaminophen (Tylenol) toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acetaminophen (Tylenol) Toxicity

Administer N-acetylcysteine (NAC) immediately for any suspected or confirmed acetaminophen overdose—ideally within 8 hours of ingestion to maximize efficacy, but NAC remains beneficial and should never be withheld even in late presentations beyond 24 hours. 1

Immediate Initial Management

First Steps (Within 4 Hours of Presentation)

  • Give activated charcoal (1 g/kg orally) just prior to starting NAC if the patient presents within 4 hours of ingestion 1, 2
  • Do not delay NAC while administering activated charcoal—give NAC immediately after charcoal 1
  • Empty the stomach promptly by lavage or induce emesis with syrup of ipecac (15 mL for children, 30 mL for adults) if within the first hour 2

Laboratory Assessment

Draw blood immediately for: 1, 2

  • Acetaminophen level (must be drawn 4-24 hours post-ingestion for nomogram use)
  • AST, ALT, bilirubin
  • Prothrombin time/INR
  • Creatinine, BUN
  • Blood glucose and electrolytes

NAC Administration Protocol

When to Start NAC Immediately (Do Not Wait for Labs)

Start NAC without delay in these scenarios: 1, 3

  • Any acetaminophen level plotting above the "possible toxicity" line on the Rumack-Matthew nomogram
  • Unknown or unreliable time of ingestion with detectable acetaminophen
  • Any evidence of hepatotoxicity (elevated AST/ALT)
  • Suspected or confirmed acute liver failure
  • Extended-release formulation ingestion
  • Repeated supratherapeutic ingestions (>4g per 24 hours for ≥48 hours)
  • Presentation >24 hours post-ingestion (nomogram does not apply)

NAC Dosing Regimens

Intravenous Protocol (20-hour regimen): 1, 3

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours

Oral Protocol (72-hour regimen): 1, 3, 2

  • Loading dose: 140 mg/kg orally or via nasogastric tube
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses
  • Dilute 20% solution to 5% concentration using diet cola or diet soft drinks 2
  • If using gastric tube, water may be used as diluent 2

Both regimens are equally effective, though the 72-hour oral regimen may be superior when treatment is delayed 4

Time-Critical Treatment Windows

Optimal Window (0-8 Hours)

  • NAC provides maximal hepatoprotection with only 2.9% developing severe hepatotoxicity when started within 8 hours 1
  • No difference in outcome whether NAC starts 0-4 hours or 4-8 hours post-ingestion 4

Diminished but Still Effective (8-10 Hours)

  • Severe hepatotoxicity develops in 6.1% when treatment begins within 10 hours 1, 4

Late but Still Beneficial (10-24 Hours)

  • Severe hepatotoxicity develops in 26.4% when treatment begins 10-24 hours post-ingestion 1, 4
  • Among high-risk patients treated 16-24 hours after ingestion, hepatotoxicity develops in 41%—still lower than untreated controls (58%) 1

Very Late Presentation (>24 Hours)

  • NAC should still be administered as it reduces mortality from 80% to 52% in fulminant hepatic failure regardless of time since ingestion 1
  • The Rumack-Matthew nomogram does NOT apply—base treatment decisions on acetaminophen levels and liver function tests 1

Special Clinical Scenarios

Established Acute Liver Failure

  • Administer NAC immediately regardless of time since ingestion (Level B recommendation) 1, 3
  • NAC reduces mortality from 80% to 52%, cerebral edema from 68% to 40%, and need for inotropic support from 80% to 48% 1
  • Early NAC treatment (<10 hours) results in 100% survival without progression 1
  • Contact liver transplant center immediately 1
  • Requires ICU-level care 1

Repeated Supratherapeutic Ingestions

Treat with NAC if: 1

  • Serum acetaminophen ≥10 mg/mL, OR
  • AST or ALT >50 IU/L, OR
  • ≥10g or 200 mg/kg (whichever is less) during a single 24-hour period, OR
  • ≥6g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours

High-Risk Populations (Lower Treatment Threshold)

Treat even with levels in "non-toxic" range for: 1

  • Chronic alcohol consumption (severe hepatotoxicity documented with doses as low as 4-5 g/day)
  • Fasting patients
  • Patients taking enzyme-inducing drugs

Extended-Release Formulations

  • Standard NAC dosing applies 3
  • Requires extended monitoring due to prolonged absorption 1
  • May need longer NAC treatment course 1

Massive Overdoses

  • Consider adjunctive therapies: fomepizole and hemodialysis/CVVH 5
  • Increase NAC dosing beyond standard protocol 1
  • For CVVH: IV NAC at 12.5 mg/kg/h plus oral NAC at 70 mg/kg every 4 hours 5

When to Stop NAC

Standard Criteria for Discontinuation

NAC can be stopped when ALL of the following are met: 1

  • Acetaminophen level is undetectable
  • AST and ALT remain normal (not just "stable"—must be normal)
  • No coagulopathy
  • Patient is clinically well

Scenarios Requiring Extended Treatment Beyond Standard Protocol

Continue NAC longer than standard protocol for: 1

  • Delayed presentation (>24 hours post-ingestion)
  • Extended-release acetaminophen
  • Repeated supratherapeutic ingestions
  • Unknown time of ingestion with detectable levels
  • Chronic alcohol use
  • Any elevation in AST or ALT above normal

Red Flags Mandating Continuation or Restart of NAC

Do NOT stop NAC or restart immediately if: 1

  • Any elevation in AST or ALT above normal
  • Rising transaminases
  • Any coagulopathy (elevated INR)
  • Detectable acetaminophen level
  • Clinical signs of hepatotoxicity

If hepatotoxicity develops (AST/ALT >1000 IU/L), restart NAC immediately and continue until transaminases are declining and INR normalizes 1

Supportive Care

Monitoring

  • Repeat AST, ALT, bilirubin, PT/INR, creatinine, BUN, glucose, and electrolytes daily if acetaminophen level is in toxic range 2
  • Monitor for complications: encephalopathy, coagulopathy, renal failure, metabolic derangements 1

Specific Interventions

  • Maintain fluid and electrolyte balance 2
  • Treat hypoglycemia as necessary 2
  • Administer vitamin K1 if PT ratio >1.5 2
  • Give fresh frozen plasma if PT ratio >3.0 2
  • Avoid diuretics and forced diuresis 2

ICU-Level Care Indications

  • Severe hepatotoxicity (AST >1000 IU/L) 1
  • Any coagulopathy 1
  • Evidence of acute liver failure 1

Critical Pitfalls to Avoid

  1. Never delay NAC while awaiting confirmatory acetaminophen levels if there is strong suspicion of overdose 1

  2. Low or absent acetaminophen levels do NOT rule out acetaminophen poisoning if ingestion was remote or occurred over several days 1

  3. The Rumack-Matthew nomogram is INVALID for: 1

    • Presentations >24 hours post-ingestion
    • Repeated supratherapeutic ingestions
    • Extended-release formulations
    • Unknown time of ingestion
  4. Patients may present with elevated transaminases despite "no risk" stratification on nomogram due to inaccurate history or increased susceptibility 1

  5. If patient vomits oral NAC within 1 hour of administration, repeat that dose 2

  6. For persistent vomiting, administer NAC via duodenal intubation rather than withholding treatment 2

  7. Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with acetaminophen poisoning—treat with NAC even without confirmatory history 1

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.